Information Provided By: 
Fly News Breaks for August 19, 2016
EMR
Aug 19, 2016 | 07:45 EDT
Buckingham analyst Joshua Pokrzywinski downgraded Emerson (EMR) to Underperform and reduced its price target to $44 from $49. The analyst believes the purchase of Pentair's (PNR) Valves & Controls business adds increased risk to earnings over the next several years, including dividend sustainability, while diluting the quality of the portfolio. Pokrzywinski believes the strategic overlap is less than ideal with the high quality Process portfolio and sees synergy targets as aggressive absent pricing improvement.
News For EMR From the Last 2 Days
There are no results for your query EMR
